Electric Literature of 41731-23-1. Chemistry is an experimental science, and the best way to enjoy it and learn about it is performing experiments.Introducing a new discovery about 41731-23-1, Name is 2-Bromo-5-methylthiazole
The nonselective glucocorticoid receptor (GR) antagonist mifepristone has been approved in the U.S. for the treatment of selected patients with Cushing?s syndrome. While this drug is highly effective, lack of selectivity for GR leads to unwanted side effects in some patients. Optimization of the previously described fused azadecalin series of selective GR antagonists led to the identification of CORT125134, which is currently being evaluated in a phase 2 clinical study in patients with Cushing?s syndrome.
If you are hungry for even more, make sure to check my other article about 41731-23-1. Electric Literature of 41731-23-1
Reference£º
Thiazole | C3H2581NS – PubChem,
Thiazole | chemical compound | Britannica